AbbVie Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2830 www.abbvie.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc.

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn - Apr 21st, 2026 1:34 pm
Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder? - Apr 21st, 2026 8:30 am
Here's Why AbbVie (ABBV) Fell More Than Broader Market - Apr 20th, 2026 3:45 pm
Trump Signed a Psychedelic Drugs Order—and These 4 Stocks Surged - Apr 20th, 2026 2:34 pm
AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada - Apr 20th, 2026 1:00 pm
Why I Can’t Stop Buying AbbVie Stock - Apr 20th, 2026 8:37 am
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics - Apr 20th, 2026 8:19 am
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target? - Apr 20th, 2026 8:18 am
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook - Apr 20th, 2026 8:17 am
Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth? - Apr 20th, 2026 6:34 am
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases - Apr 20th, 2026 12:30 am
AbbVie (ABBV) Is One Of The Major Stock To Buy According To Wall Street - Apr 19th, 2026 11:31 pm
3 Stocks I Plan to Hold for the Next 20 Years - Apr 18th, 2026 3:06 am
Top Analyst Reports for Microsoft, AbbVie & BHP - Apr 17th, 2026 3:16 pm
AbbVie Trades Below 50-Day and 200-Day SMA: How to Play the Stock - Apr 17th, 2026 9:51 am
AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit - Apr 17th, 2026 8:22 am
Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris - Apr 17th, 2026 4:17 am
Why AbbVie Is a No-Brainer Stock to Buy on the Dip - Apr 16th, 2026 2:01 pm
Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031 - Apr 16th, 2026 9:24 am
1 Value Stock Worth Your Attention and 2 That Underwhelm - Apr 16th, 2026 7:46 am